Zdrowie i gospodarka · 23/09/1997

FDA Approves Mallinckrodt's Albunex for Premarket Approval

The FDA has approved Mallinckrodt's supplemental application for premarket approval of Albunex, a medical imaging agent, following the recommendation of the Radiological Devices Panel and notification by the Center for Devices and Radiological Health on June 17, 1997.